Literature DB >> 32121066

Micro RNA Expression after Ingestion of Fucoidan; A Clinical Study.

Nuri Gueven1, Kevin J Spring2, Sandra Holmes1, Kiran Ahuja3, Raj Eri3, Ah Young Park4, J Helen Fitton4.   

Abstract

Fucoidans are a class of fucose-rich sulfated polysaccharides derived from brown macroalgae that exert a range of biological activities in vitro and in vivo. To generate an unbiased assessment of pathways and processes affected by fucoidan, a placebo-controlled double-blind pilot study was performed in healthy volunteers. Blood samples were taken immediately before and 24 h after ingestion of a single dose of 1 g of Undaria pinnatifida fucoidan (UPF) or placebo. Levels of isolated miRNAs were analyzed using Taqman Open Array Human MicroRNA panels. Out of 754 miRNAs screened, UPF affected a total of 53 miRNAs. Pathway analysis using the TALOS data analysis tool predicted 29 different pathways and processes that were largely grouped into cell surface receptor signaling, cancer-related pathways, the majority of which were previously associated with fucoidans. However, this analysis also identified nine pathways and processes that have not been associated with fucoidans before. Overall, this study illustrates that even a single dose of fucoidans has the potential to affect the expression of genes related to fundamental cellular processes. Moreover, it confirms previous data that fucoidans influence immunity, cancer cells, inflammation, and neurological function.

Entities:  

Keywords:  clinical; fucoidan; microRNA, anti-inflammatory, anti-cancer

Year:  2020        PMID: 32121066     DOI: 10.3390/md18030143

Source DB:  PubMed          Journal:  Mar Drugs        ISSN: 1660-3397            Impact factor:   5.118


  5 in total

1.  The Prebiotic Effect of Australian Seaweeds on Commensal Bacteria and Short Chain Fatty Acid Production in a Simulated Gut Model.

Authors:  Emer Shannon; Michael Conlon; Maria Hayes
Journal:  Nutrients       Date:  2022-05-23       Impact factor: 6.706

2.  Viral inhibitors derived from macroalgae, microalgae, and cyanobacteria: A review of antiviral potential throughout pathogenesis.

Authors:  Daman Reynolds; Michael Huesemann; Scott Edmundson; Amy Sims; Brett Hurst; Sherry Cady; Nathan Beirne; Jacob Freeman; Adam Berger; Song Gao
Journal:  Algal Res       Date:  2021-05-18       Impact factor: 4.401

3.  Evaluation of a Brown Seaweed Extract from Dictyosiphon foeniculaceus as a Potential Therapeutic Agent for the Treatment of Glioblastoma and Uveal Melanoma.

Authors:  Philipp Dörschmann; Christina Schmitt; Kaya Saskia Bittkau; Sandesh Neupane; Michael Synowitz; Johann Roider; Susanne Alban; Janka Held-Feindt; Alexa Klettner
Journal:  Mar Drugs       Date:  2020-12-08       Impact factor: 5.118

4.  Fucoidan-Mediated Inhibition of Fibrotic Properties in Oral Submucous Fibrosis via the MEG3/miR-181a/Egr1 Axis.

Authors:  Chih-Yuan Fang; Szu-Han Chen; Chun-Chung Huang; Yi-Wen Liao; Shih-Chi Chao; Cheng-Chia Yu
Journal:  Pharmaceuticals (Basel)       Date:  2022-07-05

Review 5.  Seaweed Components as Potential Modulators of the Gut Microbiota.

Authors:  Emer Shannon; Michael Conlon; Maria Hayes
Journal:  Mar Drugs       Date:  2021-06-23       Impact factor: 5.118

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.